Myocardial infarction in elderly patients: How to assess their bleeding risk?

Editorial Focus on Koller et al. Thromb Haemost 2015; 114: 1085-1091.

• References

• 1 Ruff CT, Braunwald E. The evolving epidemiology of acute coronary syndromes. Nat Rev Cardiol 2011; 8: 140-147.
• 2 Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276.
• 3 Lee PY, Alexander KP, Hammill BG. et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. J Am Med Assoc 2001; 286: 708-713.
• 4 Melgarejo-Moreno A, Galcera-Tomas J, Garcia-Al-berola A. et al. Clinical and prognostic characteristics associated with age and gender in acute myocardial infarction: a multihospital perspective in the Murcia region of Spain. Eur J Epidemiol 1999; 15: 621-629.
• 5 Yan RT, Yan AT, Tan M. et al. Age-related differences in the management and outcome of patients with acute coronary syndromes. Am Heart J 2006; 151: 352-359.
• 6 Alexander KP, Newby LK, Armstrong PW. et al. Acute coronary care in the elderly, part II: ST-segment elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 2007; 115: 2570-2589.
• 7 Alexander KP, Newby LK, Cannon CP. et al. Acute coronary care in the elderly, part I: Non ST-segment elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 2007; 115: 2549-2569.
• 8 Modi KA, Nylk TM, Sheridan FM. Medical management of acute ST elevation myocardial infarction. J La State Med Soc 2001; 153: 284-290.
• 9 Ohman EM, Harrington RA, Cannon CP. et al. Intravenous thrombolysis in acute myocardial infarction. Chest 2001; 119 (1 Suppl) 253S-277S.
• 10 Weaver WD, Simes RJ, Betriu A. et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. J Am Med Assoc 1997; 278: 2093-2098.
• 11 Berger AK, Schulman KA, Gersh BJ. et al. Primary coronary angioplasty vs thrombolytics for the management of acute myocardial infarction in elderly patients. J Am Med Assoc 1999; 282: 341-348.
• 12 Ribeiro EE, Silva LA, Carneiro R. et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993; 22: 376-380.
• 13 Grinfeld L, Berrocal D, Bellardi J. et al. Fibrinolytics versus primary angioplasty in acute myocardial infarction. J Am Coll Cardiol 1996; 27: A222
• 14 Zijlstra F, Beukema WP, van ’t Hof AW. et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. JACC 1997; 29: 958-1012.
• 15 Ribichini F, Steffenino G, Dellavalle A. et al. Primary angioplasty versus thrombolysis in inferior acute myocardial infarction with anterior ST depressionCa single-center randomized study. J Am Coll Cardiol 1996; 27: A221
• 16 Garcia E, Elizaga J, Soriano J. Primary angioplasty versus thrombolysis with t-PA in the anterior myocardial infarction. J Am Coll Cardiol 1997; 29: A-389
• 17 Van de Werf F, Bax J, Betriu A. et al. ESC Committee for Practice Guidelines (CPG) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-2945.
• 18 Antman EM, Anbe DT, Armstrong PW. et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 2004; 44: 671-719.
• 19 Kushner FG, Hand M, Smith Jr SC. et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009; 54: 2205-2241.
• 20 Moscucci M, Fox KA, Cannon CP. et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1815-1823.
• 21 Marso SP, Amin AP, House JA. et al. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. J Am Med Assoc 2010; 303: 2156-2164.
• 22 Ndrepepa G, Berger PB, Mehilli J. et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 2008; 51: 690-697.
• 23 Chhatriwalla AK, Amin AP, Kennedy KF. et al. Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. J Am Med Assoc 2013; 309: 1022-1029.
• 24 Rao SV, Dai D, Subherwal S. et al. Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients. JACC Cardiovasc Interv 2012; 5: 958-965.
• 25 Marso SP, Amin AP, House JA. et al. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. J Am Med Assoc 2010; 303: 2156-2164.
• 26 Ariza-Sole A, Salazar-Mendiguchia J, Lorente V. et al. Predictive ability of bleeding risk scores in the routine clinical practice. Eur Heart J Acute Cardiovasc Care. 2014 Epub ahead of print.
• 27 Abu-Assi E, Raposeiras-Roubin S, Lear P. et al. Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome. Eur Heart J Acute Cardiovasc Care 2012; 1: 222-231.
• 28 Ariza-Sole A, Formiga F, Lorente V. et al. Efficacy of bleeding risk scores in elderly patients with acute coronary syndromes. Rev Esp Cardiol 2014; 67: 463-470.
• 29 Faustino A, Mota P, Silva J. Non-ST-elevation acute coronary syndromes in octogenarians: Applicability of the GRACE and CRUSADE scores. Rev Port Cardiol. 2014 Epub ahead of print
• 30 Koller L, Rothgerber DJ, Sulzgruber P. et al. History of previous bleeding and C-reactive protein improve assessment of bleeding risk in elderly patients (> 80 years) with myocardial infarction. Thromb Haemost 2015; 114: 1085-1091.
• 31 Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-694.
• 32 Mehran R, Rao SV, Bhatt DL. et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736-2747.
• 33 Aradi D, Collet JP, Mair J. et al. Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association of the European Society of Cardiology; Working Group on Thrombosis of the European Society of Cardiology. Platelet function testing in acute cardiac care – is there a role for prediction or prevention of stent thrombosis and bleeding?. Thromb Haemost 2015; 113: 221-230.
• 34 De Luca G, Navarese E, Marino P. Risk profile and benefits from Gp Ilb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. Eur Heart J 2009; 30: 2705-2713.
• 35 Alexopoulos D, Stavrou K, Koniari I. et al. Ticagrelor vs prasugrel one-month maintenance therapy: impact on platelet reactivity and bleeding events. Thromb Haemost 2014; 112: 551-557.